Evidence map›Paper›PMID 30023807›Full record

ArticleACS omega2018

Enabling Biocatalysis by High-Throughput Protein Engineering Using Droplet Microfluidics Coupled to Mass Spectrometry.

Xue W Diefenbach, Iman Farasat, Erik D Guetschow, Christopher J Welch, Robert T Kennedy, Shuwen Sun, Jeffrey C Moore

Open access · goldAbstract read
In one paragraph

Article in ACS omega, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
6.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 113 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Progresses in Cell-Free In Vitro Evolution.Advances in biochemical engineering/biotechnology · 2023
    Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Xue W DiefenbachMerck Research Laboratory, Merck & Co., Inc., 126 E Lincoln Avenue, Rahway, New Jersey 07065, United States.
Iman FarasatMerck Research Laboratory, Merck & Co., Inc., 126 E Lincoln Avenue, Rahway, New Jersey 07065, United States.
Erik D GuetschowMerck Research Laboratory, Merck & Co., Inc., 126 E Lincoln Avenue, Rahway, New Jersey 07065, United States.
Christopher J WelchMerck Research Laboratory, Merck & Co., Inc., 126 E Lincoln Avenue, Rahway, New Jersey 07065, United States.
Robert T KennedyDepartment of Chemistry, University of Michigan, 930 N University Avenue, Ann Arbor, Michigan 48109, United States.
Shuwen SunMerck Research Laboratory, Merck & Co., Inc., 126 E Lincoln Avenue, Rahway, New Jersey 07065, United States.
Jeffrey C MooreMerck Research Laboratory, Merck & Co., Inc., 126 E Lincoln Avenue, Rahway, New Jersey 07065, United States.
Merck & Co., Inc., Rahway, NJ, USA (United States) · USUniversity of Michigan · US

Funding

High throughput mass spectrometry and electrophoresis assay systemsR01GM102236 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI KENNEDY, ROBERT T · 2012 to 2015
$1.1M
NIGMS NIH HHS R01 GM102236
6 · The paper itself

Abstract

Directed Evolution is a key technology driving the utility of biocatalysis in pharmaceutical synthesis. Conventional approaches to Directed Evolution are conducted using bacterial cells expressing enzymes in microplates, with catalyzed reactions measured by HPLC, high-performance liquid chromatography-mass spectrometry (HPLC-MS), or optical detectors, which require either long cycle times or tailor-made substrates. To better fit modern, fast-paced process chemistry development where solutions are rapidly needed for new substrates, droplet microfluidics interfaced with electrospray ionization (ESI)-MS provides a label-free high-throughput screening platform. To apply this method to industrial enzyme screening and to explore potential approaches that may further improve the overall throughput, we optimized the existing droplet-MS methods. Carryover between droplets, traditionally a significant issue, was reduced to undetectable level by replacing the stainless steel ESI needle with a Teflon needle within a capillary electrophoresis (CE)-MS source. Throughput was improved to 3 Hz with a wide range of droplet sizes (10-50 nL) by tuning the sheath flow within the CE-MS source. The optimized method was demonstrated by screening reactions using two different transaminase libraries. Good correlations (

Identifiers

PMID30023807
PMCPMC6044804
OpenAlexW2786260569

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.